Document is current
Any future updates will be listed below
-
Authors
Gagner, Michel
Fried, Martin
Michalsky, David
Dolezalova, Karen
Sramkova, Petra
Brezina, Jan
Baliarova, Dasa
Hlavata, Lucie
Novak, Michal
Bartos, Jaroslav
Mullerova, Sarka
-
Funding
Funding for this research was provided by:
GT Metabolic
- License Information
-
More Information
Article History
Received: 30 January 2025
Revised: 2 April 2025
Accepted: 5 April 2025
First Online: 7 May 2025
Declarations
:
: This study was supported by a research grant from GT Metabolic Solutions, Inc. (San Jose, CA), a company invested in magnetic surgery. M. Gagner has multiple patents related to magnetic technology, is a cofounder of GT with stock options, and is a consultant for Lexington Medical, Inc. with stock options in Lexington Medical, Inc. M. Fried is the principal investigator of the study with no conflicts to declare. D. Michalsky is a sub-investigator with no conflicts. K. Dolezalova is a sub-investigator with no conflicts. P. Sramkova is the study diabetologist-obesitologist with no conflicts. J. Brezina is a sub-investigator with no conflicts. D. Baliarova is a Ph.D. student with no conflicts. L. Hlavata is the study coordinator with no conflicts. M. Novak is the study radiologist with no conflicts. J. Bartos is a member of the study endoscopy team with no conflicts. S. Mullerova is the study nurse with no conflicts to declare.
